European biotech’s reliance on later-stage US capital means that “European VCs’ role is to catalyze that US interest and form substantial funding syndicates,” says Sander Slootweg, co-owner and managing partner at Naarden, Netherlands-based @ForbionLifeSci
2,545 followers
1,160 followers
RT @NatureBiotech: European biotech companies raised unprecedented amounts of capital in 2019. Our April Feature looked at Europe’s biotech…
1,160 followers
RT @NatureBiotech: European biotech companies raised unprecedented amounts of capital in 2019. Our April Feature looked at Europe’s biotech…
1,269 followers
RT @NatureBiotech: European biotech companies raised unprecedented amounts of capital in 2019. Our April Feature looked at Europe’s biotech…